BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9212242)

  • 1. Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.
    de Graaf H; Maelandsmo GM; Ruud P; Forus A; Oyjord T; Fodstad O; Hovig E
    Int J Cancer; 1997 Jul; 72(1):191-6. PubMed ID: 9212242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
    Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
    Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood.
    Helfrich W; ten Poele R; Meersma GJ; Mulder NH; de Vries EG; de Leij L; Smit EF
    Br J Cancer; 1997; 76(1):29-35. PubMed ID: 9218728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time reverse transcription-polymerase chain reaction assay for GA733-2 mRNA in the detection of metastatic carcinoma cells in serous effusions.
    Nagel H; Werner C; Hemmerlein B
    Am J Clin Pathol; 2003 Dec; 120(6):888-901. PubMed ID: 14671978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
    Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
    J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein-2 promoter as a novel anti-cancer treatment.
    Gommans WM; McLaughlin PM; Lindhout BI; Segal DJ; Wiegman DJ; Haisma HJ; van der Zaal BJ; Rots MG
    Mol Carcinog; 2007 May; 46(5):391-401. PubMed ID: 17186549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy.
    McLaughlin PM; Kroesen BJ; Dokter WH; van der Molen H; de Groot M; Brinker MG; Kok K; Ruiters MH; Buys CH; de Leij LF
    Cancer Immunol Immunother; 1999 Sep; 48(6):303-11. PubMed ID: 10473805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines.
    McLaughlin PM; Trzpis M; Kroesen BJ; Helfrich W; Terpstra P; Dokter WH; Ruiters MH; de Leij LF; Harmsen MC
    Cancer Gene Ther; 2004 Sep; 11(9):603-12. PubMed ID: 15243630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context.
    Gommans WM; van Eert SJ; McLaughlin PM; Harmsen MC; Yamamoto M; Curiel DT; Haisma HJ; Rots MG
    Cancer Gene Ther; 2006 Feb; 13(2):150-8. PubMed ID: 16096650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
    Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
    J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR.
    Perey L; Benhattar J; Peters R; Jaunin P; Leyvraz S
    Br J Cancer; 2001 Nov; 85(11):1713-21. PubMed ID: 11742493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells.
    Ruud P; Fodstad O; Hovig E
    Int J Cancer; 1999 Jan; 80(1):119-25. PubMed ID: 9935241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.
    McLaughlin PM; Harmsen MC; Dokter WH; Kroesen BJ; van der Molen H; Brinker MG; Hollema H; Ruiters MH; Buys CH; de Leij LF
    Cancer Res; 2001 May; 61(10):4105-11. PubMed ID: 11358833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer.
    Zhong XY; Kaul S; Bastert G
    Arch Gynecol Obstet; 2001 Jan; 264(4):177-81. PubMed ID: 11205703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.
    Berois N; Varangot M; Sóñora C; Zarantonelli L; Pressa C; Laviña R; Rodríguez JL; Delgado F; Porchet N; Aubert JP; Osinaga E
    Int J Cancer; 2003 Feb; 103(4):550-5. PubMed ID: 12478674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
    Fava TA; Desnoyers R; Schulz S; Park J; Weinberg D; Mitchell E; Waldman SA
    J Clin Oncol; 2001 Oct; 19(19):3951-9. PubMed ID: 11579116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates.
    Maas RA; Bruning PF; Breedijk AJ; Top B; Peterse HL
    Lab Invest; 1995 Jun; 72(6):760-4. PubMed ID: 7540237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.
    Gerhard M; Juhl H; Kalthoff H; Schreiber HW; Wagener C; Neumaier M
    J Clin Oncol; 1994 Apr; 12(4):725-9. PubMed ID: 7512130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.